1 |
Shils ME, Young VR. 1988. Modern nutrition in health and disease. 7th ed. Lea and Febiger Publisher, Philadelphia. p 763
|
2 |
Christenson RH. 1997. Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593
DOI
ScienceOn
|
3 |
Prestwood KM, Pilbeam CC, Raisz LG. 1995. Treatment of osteoporosis. Annu Rev Med 46: 249-256
DOI
ScienceOn
|
4 |
Anderson JJ, Garner SC. 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557
DOI
ScienceOn
|
5 |
Lindsay R. 1993. Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumato 7: 499-513
DOI
ScienceOn
|
6 |
Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca HF. 1994. Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 9: 607-614
|
7 |
Ettinger B, Genant HK, Cann CE. 1985. Long-term estrogen replacement therapy prevents bone loss and fracture. Ann Intern Med 102: 319-324
DOI
ScienceOn
|
8 |
Edward MW, Bain SD, Bailey MC, Lantry MM, Howard GA. 1992. 17-estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for evaluation of bone targeted estrogens. Bone 13: 29-34
DOI
ScienceOn
|
9 |
Ernst M, Heath JK, Rodan GA. 1989. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125: 825-833
DOI
ScienceOn
|
10 |
McCarthy TL, Centrella M. 1993. Regulation of IGF activity in bone. Adv Exp Med Bio 343: 407-414
|
11 |
Genant HK, Baylink DJ, Gallagher JC. 1989. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846
DOI
ScienceOn
|
12 |
Murphy LJ, Ghahary A. 1990. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Rev 11: 443-453
DOI
ScienceOn
|
13 |
Anderson JJ, Garner SC 1998. Phytoestrogen and bone. Baillieres Clin Endocrinol Metab 12: 543-557
DOI
ScienceOn
|
14 |
Adlercreutz H, Mazur W. 1997. Phyto-oestrogens and Western diseases. Ann Med 29: 95-120
DOI
ScienceOn
|
15 |
Setchell KDR. 1998. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333-1346
DOI
|
16 |
Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. 1999. Health potential of soy isoflavones for menopausal women. Public Health Nut 2: 489-504
|
17 |
Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ. 2001. Soy bean ethanol extract increases the function of osteoblastic MC3T3-El cells. Phytochemistry 56: 733-739
DOI
ScienceOn
|
18 |
Gehm BD, McAndrews JM, Chien PY, Jameson JL. 1997. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143
|
19 |
Setchell KDR, Cassidy A. 1999. Dietary isoflavones: biological effects and relevance to human health. J Nutr 129: 758-767
DOI
|
20 |
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja Sc. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167
DOI
|
21 |
Panti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH. 1998 The phytoestrogen genistein reduces bone loss in short-term ovariactomized rats. Osteoporo Int 8: 274-281
DOI
ScienceOn
|
22 |
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167
DOI
|
23 |
Mizutani K, Ikeda K, Kawai Y, Yamori Y. 1998. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-El cells. Biochem Biophys Res Commun 253: 859-863
DOI
ScienceOn
|
24 |
Picherit C, Coxam V, Bennetau-Pelissero C, Kati-Coulibaly S, Davicco MJ, Lebecque P, Barlet JP. 2000. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130: 1675-1681
|
25 |
Ljunghall S, Lindh E. 1989. Assesment of bone turnover with biochemical makers. J Intern Med 225: 219-220
DOI
ScienceOn
|
26 |
Sugimoto E, Yamaguchi M. 2000a. Anabolic effect of genistein in osteoblastic MC3T3-El cells. Int J Mol Med 5: 515-520
|
27 |
Sugimoto E, Yamaguchi M. 2000b. Stimulatory effect of daidzein in osteoblastic MC3T3-El cells. Biochem Pharmacol 59: 471-475
DOI
ScienceOn
|
28 |
Ernst M, Rodan GA. 1991. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 8: 1081-1089
|
29 |
Tomkinson A, Reeve J, Shaw RW, Noble BS. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 3128-3135
DOI
ScienceOn
|
30 |
Nasu M, Sugimoto T, Kaji H, Chihara K. 2000. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cell: role of insulin like growth factor (IGF)-I and IGF-binding prtein-5. J Endocrinol 167: 305-313
DOI
ScienceOn
|
31 |
Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. 1990. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res 5: 311-319
DOI
ScienceOn
|
32 |
Vedi S, Purdie DW, Ballard P, Bord S. Cooper AC, Compston JE. 1999. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Osteoporos Int 10: 52-58
DOI
ScienceOn
|
33 |
Wlodarski KH, Reddi AH. 1986. Alkaline phosphatase as a marker of osteoinductive cells. Calcif Tissue Int 39: 382-385
DOI
ScienceOn
|
34 |
Lazowski D, Fraher L, Hodsman A, Steer B, Modrowski D, Han V. 1994. Regional variation of insulin like growth factor-I gene expression in mature rat bone and cartilage. Bone 15: 563-576
DOI
ScienceOn
|
35 |
Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. 1993. Differential expression of insulin-like growth factor-1 (IGF-I) and IGF-II messenger ribonucleic acid in rowin rat bone. Endocrinology 132: 1158-1167
DOI
ScienceOn
|
36 |
Gao YH, Yamaguchi M. 1999. Anabolic effect of daidzein on cortical in tissue culture: Comparison with genistein effect. Mol Cell Biochem 194: 93-98
DOI
ScienceOn
|
37 |
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. 1998. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68: 1375-1379
DOI
|
38 |
Huynh H. 1998. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor 1. Int J Oncol 12: 427-432
|